Oncomine research premium edition, annual license;2 user license renewal for oncomine research premium edition expiring on april 22, 2018. Primary user=ANA robles; additional user=ANU budhu.

Ended Awarded

Contract number
HHSN26100083
Awardee
Awarding agency
Obligated
$4,599

Award facts

Contract value 100% obligated
$4,599.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
J066 Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a contract award from the National Cancer Institute for a two-user annual license renewal of Oncomine Research Premium Edition software, expiring April 22, 2018. The contract, valued at $4,599.00, was issued under a Blanket Purchase Agreement (BPA) call with a firm fixed price structure and no set-aside designation. Primary and additional users were designated as Ana Robles and Anu Budhu, respectively. The place of performance was Bethesda, Maryland. This award reflects the National Cancer Institute's continued investment in genomic analysis and oncology research tools that support the institute's mission to conduct and fund cancer research across its scientific programs.

The contract was awarded on April 11, 2017, with an ultimate completion date of April 22, 2018. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, is a leading supplier of scientific instruments, reagents, and biotechnology products to federal agencies. The company's extensive federal contracting history includes similar software licensing and laboratory equipment support to the National Institutes of Health and other health and research agencies. This software license renewal supports NCI researchers' access to the Oncomine platform, a comprehensive tool for oncology data analysis and genomic research interpretation.

Quick answers

Who was awarded contract HHSN26100083?

HHSN26100083 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on April 11, 2017.

How much is contract HHSN26100083 worth?

The government has obligated $4,599 on HHSN26100083.

Is contract HHSN26100083 an order under another contract?

Yes. HHSN26100083 is a BPA call under HHSN263201200063B, a blanket purchase agreement.

Was contract HHSN26100083 competed?

The extent of competition for HHSN26100083 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award